Head & Neck/Thyroid Cancers
Case Reports
Salivary ductal adenocarcinoma with complete response to androgen blockade
New Therapies
Meeting the potential of immunotherapy: new targets provide rational combinations
From the Journals
HPV positivity associated with good esophageal adenocarcinoma outcomes
Patients with esophageal adenocarcinoma who were HPV positive had significantly better disease-free and overall survival.
Case Reports
Effective management of severe radiation dermatitis after head and neck radiotherapy
Original Report
The impact of inpatient rehabilitation on outcomes for patients with cancer
Conference Coverage
H&N cancer may be undertreated in women
CHICAGO – Female patients with H&N cancer had almost twice the ratio of cancer deaths to noncancer deaths.
Conference Coverage
Head and neck cancers: Women less commonly receive intensive chemo
CHICAGO - Senior study author Dr. Jed A. Katzel discusses ongoing research to understand the reasons behind the apparent disparities.
Conference Coverage
New remote monitoring system lessens symptoms in head and neck cancer
The CYCORE system, which harnesses wireless sensor and mobile technology to remotely monitor vitals and symptoms, reduces symptom severity in...
News
FDA approves dabrafenib/trametinib for BRAF-positive anaplastic thyroid cancer
Of 23 patients, 57% experienced a partial response and 4% experienced a full response.
Case Reports
Resolution of refractory pruritus with aprepitant in a patient with microcystic adnexal carcinoma
Conference Coverage
Probe linked to smartphone found effective in diagnosing oral cancer
DALLAS – The device provides high-resolution polarized white light images in combination with autofluorescence imaging capability.